Presentation will include an update on the development and launch preparations of Cylembio™ (imsapepimut and etimupepimut, adjuvanted) NEW YORK, Feb. 20, 2025 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: ...

Investors and the general public are invited to listen to a live webcast of the presentation through the "Investors" section on Artivabio.com. A webcast replay will be made available following the ...

Michael Kennedy: "We've really hit an amazing stride in terms of basket innovation, and we've really embraced some new ...

The FDA has accepted an investigational new drug application for ALLO-329, an allogeneic chimeric antigen receptor T-cell ...

The Phase IIa study REIMAGINE evaluated the safety and preliminary efficacy of vafidemstat in agitation/aggression in borderline personality disorder (BPD), attention-deficit/hyperactivity disorder ...

As federal policy updates come out of Washington at a rapid pace under a new presidential administration, ASC leaders and physicians remain watchful of policy shifts and legislation that will directly ...

Strong early U.S. YORVIPATH® launch with 908 prescriptions as of Feb. 7, 2025; YORVIPATH full year 2024 revenue of €28.7 million - Following pre-NDA meeting with FDA, on track to submit TransCon CNP ...

German businesses are sounding the alarm ahead of the federal election, warning of further stagnation. They’re calling for ...

Nigeria's annual inflation rate stood at 24.48% in January, the statistics agency said on Tuesday, well down from the ...

Auburn defeated Alabama in a matchup of the top two teams in college basketball. Check out the scores, updates and highlights from the Tigers' win: ...

Rajni Singh, 43, overcame postpartum depression and a suicide attempt to become a competitive bodybuilder, transforming her ...

They are also testing Padcev in non-muscle invasive bladder cancer (NMIBC) as well as for first-line treatment of MIBC regardless in an all-comer population, and are running a basket trial ...